ICU MEDICAL ($ICUI) posted quarterly earnings results for Q4 2025 on Thursday, February 19th. The company reported earnings of $1.91 per share, beating estimates of $1.73 by $0.18. The company also reported revenue of $535,940,000, missing estimates of $541,245,996 by $-5,305,996.
You can see Quiver Quantitative's $ICUI stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ICU MEDICAL Insider Trading Activity
ICU MEDICAL insiders have traded $ICUI stock on the open market 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $ICUI stock by insiders over the last 6 months:
- DANIEL WOOLSON (VP, GM-Infusion Capital) sold 2,897 shares for an estimated $441,364
- ELISHA W FINNEY sold 1,285 shares for an estimated $180,439
- DAVID C. GREENBERG has made 2 purchases buying 1,200 shares for an estimated $151,698 and 0 sales.
- VIRGINIA RUTH SANZONE (VP, General Counsel) sold 930 shares for an estimated $132,380
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ICU MEDICAL Hedge Fund Activity
We have seen 151 institutional investors add shares of ICU MEDICAL stock to their portfolio, and 165 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MILLENNIUM MANAGEMENT LLC removed 1,001,882 shares (-92.0%) from their portfolio in Q4 2025, for an estimated $142,938,504
- NITORUM CAPITAL, L.P. removed 578,859 shares (-79.0%) from their portfolio in Q4 2025, for an estimated $82,585,813
- POINT72 ASSET MANAGEMENT, L.P. added 285,843 shares (+550.8%) to their portfolio in Q4 2025, for an estimated $40,781,220
- MACQUARIE GROUP LTD removed 285,791 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $40,773,801
- THRIVENT FINANCIAL FOR LUTHERANS added 285,648 shares (+1604.0%) to their portfolio in Q4 2025, for an estimated $40,753,400
- BROWN ADVISORY INC added 227,412 shares (+inf%) to their portfolio in Q4 2025, for an estimated $32,444,870
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 223,590 shares (-71.6%) from their portfolio in Q4 2025, for an estimated $31,899,585
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ICU MEDICAL Government Contracts
We have seen $5,758,060 of award payments to $ICUI over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- VISN 7 BIRMINGHAM AND ATLANTA VAMC INFUSION PUMPS: $4,495,382
- INFUSION PUMPS FOR MUSKOGEE AND TULSA VAMCS: $739,270
- INFUSION PUMPS: $296,000
- INFUSION PUMP EQUIPMENT AND SERVICES - PCAS: $145,791
- PIMC ICU MEDICAL IV SOLUTIONS BPA: $25,000
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
ICU MEDICAL Analyst Ratings
Wall Street analysts have issued reports on $ICUI in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keybanc issued a "Overweight" rating on 11/07/2025
- Piper Sandler issued a "Overweight" rating on 11/07/2025
To track analyst ratings and price targets for ICU MEDICAL, check out Quiver Quantitative's $ICUI forecast page.
ICU MEDICAL Price Targets
Multiple analysts have issued price targets for $ICUI recently. We have seen 2 analysts offer price targets for $ICUI in the last 6 months, with a median target of $173.5.
Here are some recent targets:
- Jason Bednar from Piper Sandler set a target price of $172.0 on 11/07/2025
- Brett Fishbin from Keybanc set a target price of $175.0 on 11/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
